Can prenatal PFAS exposure lead to PCOS in daughters when they grow up?

What's actually in it

PFOS (perfluorooctane sulfonate) was used in stain-resistant textiles, fire-resistant gear, and food packaging. It's been largely phased out but persists in the environment and accumulates in bodies. It crosses the placenta, meaning daughters born to mothers with PFOS exposure in their blood receive a fetal dose during development.

PCOS (polycystic ovary syndrome) is the most common hormonal disorder in women of reproductive age. It involves elevated androgens, disrupted ovulation, and metabolic irregularities. Its origins are at least partly prenatal: the fetal hormonal environment shapes how the female reproductive axis is programmed for life.

What the research says

A 2026 study in Mol Cell Endocrinol exposed female animal offspring to prenatal PFOS and tracked reproductive hormone levels and ovarian function as they matured. Prenatally exposed females showed elevated androgens, irregular ovarian cycles, and metabolic disruptions consistent with PCOS traits.

The mechanism involves PFOS disrupting androgen metabolism during fetal ovarian development. The fetal ovary begins establishing its hormonal programming in utero. PFOS pushes this programming toward higher androgen production, which is the central hormonal feature of PCOS.

This is animal research, but the fetal programming mechanism is consistent with how PCOS is understood to develop in humans. PFAS are plausible contributors to the rising prevalence of PCOS given their widespread exposure and effects on sex hormone pathways.

For pregnant people, reducing PFOS/PFAS exposure means avoiding nonstick cookware, stain-treated textiles, and using a certified PFAS-removing water filter during pregnancy.